C. M. Voloch, R. D. S. Francisco Junior, L. G. de Almeida, C. C. Cardoso, O. J. Brustolini, A. Gerber, A. P. Guimarães, D. Mariani, R. M. da Costa, O. F. Ferreira Júnior, Covid19-UFRJ Workgroup, LNCC-Workgroup, A. C. Cavalcanti, T. S. Frauches, C. M. B. de Mello, R. D. M. Galiez, D. Faffe, T. Castineira, A. Tanuri, A. T. R. de Vasconcelos
medRxiv, 2020
In this study, we report the sequencing of 180 new viral genomes obtained from different municipalities of the state of Rio de Janeiro from April to December 2020. We identified a novel lineage of SARS-CoV-2, originated from B.1.1.28, distinguished by five single-nucleotide variants (SNVs): C100U, C28253U, G28628U, G28975U, and C29754U. The SNV G23012A (E484K), in the receptor-binding domain of Spike protein, was widely spread across the samples. This mutation was previously associated with escape from neutralizing antibodies against SARS-CoV-2. This novel lineage emerged in late July being first detected by us in late October and still mainly restricted to the capital of the state. However, as observed for other strains it can be rapidly spread in the state. The significant increase in the frequency of this lineage raises concerns about public health management and continuous need for genomic surveillance during the second wave of infections.
Cited by 115 publications.
Field of study: Medicine